Kate Therapeutics Debuts With $51 Million Series A to Develo

Kate Therapeutics Debuts With $51 Million Series A to Develop Next-Generation Genetic Medicines to Treat Muscle and Heart Diseases

Kate Therapeutics Debuts With $51 Million Series A to Develop Next-Generation Genetic Medicines to Treat Muscle and Heart Diseases

streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Related Keywords

United States , Sharif Tabebordbar , Pardis Sabeti , Eric Wang , Clare Ozawa , Beth Seidenberg , Kevin Forrest , Prnewswire Kate Therapeutics Inc , Osage University Partners , Broad Institute , Astellas Pharma Inc , University Of Florida , Westlake Village Biopartners , Astellas Pharma , Versant Ventures , Chief Scientific Officer , Myotonic Dystrophy Type , Facioscapulohumeral Muscular Dystrophy ,